Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) FCF Margin (2016 - 2021)

Historic FCF Margin for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to 18.95%.

  • Neurocrine Biosciences' FCF Margin rose 270000.0% to 18.95% in Q3 2021 from the same period last year, while for Dec 2021 it was 28.37%, marking a year-over-year increase of 75700.0%. This contributed to the annual value of 20.81% for FY2020, which is 40200.0% up from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' FCF Margin is 18.95%, which was up 270000.0% from 34.23% recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' FCF Margin peaked at 42.46% during Q3 2019, and registered a low of 767.73% during Q2 2017.
  • Moreover, its 5-year median value for FCF Margin was 33.19% (2018), whereas its average is 28.79%.
  • Per our database at Business Quant, Neurocrine Biosciences' FCF Margin skyrocketed by 7840800bps in 2018 and then plummeted by -505000bps in 2020.
  • Over the past 5 years, Neurocrine Biosciences' FCF Margin (Quarter) stood at 40.41% in 2017, then decreased by -16bps to 33.84% in 2018, then rose by 15bps to 38.8% in 2019, then decreased by -6bps to 36.3% in 2020, then tumbled by -48bps to 18.95% in 2021.
  • Its last three reported values are 18.95% in Q3 2021, 34.23% for Q2 2021, and 35.0% during Q1 2021.